🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Fábio M. Iwamoto

Cornell University

ORCID: 0000-0003-1397-9927

Also affiliated with Columbia University Irving Medical Center, Neurological Surgery, Columbia University

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 3%percentile

1.0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Papers

Driven by 13 papers — median percentile 80. Top paper: “Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors”.

Safety, tolerability and efficacy of agonist anti-CD27 antibody (varlilumab) administered in combination with anti-PD-1 (nivolumab) in advanced solid tumors

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005147

N/A

1.7DataRank · unranked

66 citations

Michael J. Pishvaian, Margaret K. Callahan, Amy Weise, Branimir I. Šikić, Osama E. Rahma +19 more

A Transcriptome-Based Precision Oncology Platform for Patient–Therapy Alignment in a Diverse Set of Treatment-Resistant Malignancies

Cancer Discovery(2023)10.1158/2159-8290.cd-22-1020

Top 20%

1.0DataRank

Top 20%43 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +50 more

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Neuro-Oncology Advances(2024)10.1093/noajnl/vdae202

N/A

0.345DataRank · unranked

9 citations

Adam L. Cohen, Midori Eckenstein, Randy L. Jensen, Lindsay Burt, Karen L. Salzman +18 more

Evaluation of GM-CSF and AS01B adjuvants in a phase I/IIa trial of a therapeutic CMV vaccine (VBI-1901) against recurrent glioblastoma (GBM).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.2047

N/A

0.241DataRank · unranked

4 citations

David A. Reardon, Deborah Forst, Eudocia Q. Lee, Fábio M. Iwamoto, Francisco Díaz‐Mitoma +3 more

Treatment of Recurrent Glioblastoma by Chronic Convection-Enhanced Delivery of Topotecan

medRxiv(2021)10.1101/2021.12.04.21266935

N/A

0.227DataRank · unranked

3 citations

Michael Argenziano, Pavan S. Upadhyayula, Matei A. Banu, Justin A. Neira, Dominique Higgins +29 more

Causes of Death and End-of-Life Care in Patients With Intracranial High-Grade Gliomas

Neurology(2021)10.1212/wnl.0000000000013057

N/A

0DataRank · unranked

26 citations

Craig D. Blinderman, Fábio M. Iwamoto, Teri Kreisl, Mary Welch, Yazmín Odia +5 more

Pre-clinical validation of an RNA-based precision oncology platform for patient-therapy alignment in a diverse set of human malignancies resistant to standard treatments

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.10.03.462951

N/A

0DataRank · unranked

7 citations

Filemon S. Dela Cruz, Adina Grunn, Daniel Diolaiti, Audrey Mauguen, Allison R. Rainey +48 more

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Frontiers in Oncology(2020)10.3389/fonc.2020.01045

N/A

0DataRank · unranked

66 citations

Milan J. Anadkat, Matthew T. Ballo, Fábio M. Iwamoto, Suriya Jeyapalan, Renato V. La Rocca +4 more

Clinical Utility of [ 18 F]-Fluciclovine PET/MRI for Differentiating True Progression from Treatment-Related Changes in Patients with Glioblastoma

American Journal of Neuroradiology(2025)10.3174/ajnr.a9120

N/A

0DataRank · unranked

1 citations

Kellen Vo Vu, Rongwei Fu, Andrew Brandmaier, László Szidonya, Gagandeep Choudhary +41 more

A Bayesian adaptive randomized phase II multicenter trial of bevacizumab with or without vorinostat in adults with recurrent glioblastoma

Neuro-Oncology(2020)10.1093/neuonc/noaa062

N/A

0DataRank · unranked

46 citations

Jing Wu, Ying Yuan, Terri S. Armstrong, Elizabeth Vera, Jimin Wu +18 more

Randomized phase II study of rituximab, methotrexate (MTX), procarbazine, vincristine, and cytarabine (R-MPV-A) with and without low-dose whole-brain radiotherapy (LD-WBRT) for newly diagnosed primary CNS lymphoma (PCNSL).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.2501

N/A

0DataRank · unranked

59 citations

Lisa M. DeAngelis, Theodore Karrison, Joe A Bovi, Marc K. Rosenblum, Benjamin W. Corn +16 more

Diagnosis of leptomeningeal metastasis (LM) through identification of circulating tumor cells (CTCs) in cerebrospinal fluid (CSF).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3567

N/A

0DataRank · unranked

1 citations

Veena Singh, Shing Mirn Lee, David Cieremans, Andrew B. Lassman, Dawn L. Hershman +12 more

ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma

Nature Cancer(2021)10.1038/s43018-021-00260-2

N/A

0DataRank · unranked

120 citations

Andrew Chen, J. Robert Kane, Seong Jae Kang, Cynthia Kassab, Crismita Dmello +37 more